Jolly Healthcare launches KETOJOL 4:1 Jolly Healthcare has launched KETOJOL 4:1, a ketogenic diet formulation with a 4:1 fat-to-(protein + carbohydrate) ratio, for use…
FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer The study demonstrated a statistically significant improvement in progression-free survival (PFS) as assessed by a blinded…
